Premium
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease: An Overview
Author(s) -
Bailie George R.,
Massry Shaul G.
Publication year - 2005
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.2005.25.12.1687
Subject(s) - kidney disease , medicine , disease , nephrology , intensive care medicine , parathyroid hormone , bone remodeling , clinical practice , complication , bioinformatics , physical therapy , calcium , biology
The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the aberrations in bone metabolism and disease that occur as a complication of chronic kidney disease. These guidelines provide, for the first time, a standard approach to the detection and management of alterations in calcium, phosphorus, and parathyroid hormone metabolism. The problems and sequelae of soft‐tissue calcification are discussed, and recommendations are provided for reducing the associated morbidity and mortality.